Hohnloser, Stefan H.
Basic, Edin
Nabauer, Michael
Article History
Received: 24 December 2018
Accepted: 11 February 2019
First Online: 15 February 2019
Compliance with ethical standards
:
: Professor Hohnloser has served as a consultant for Bayer, BMS/Pfizer, Boehringer Ingelheim, Daiichi Sankyo and Jansen. Professor Nabauer has received lecture fees from Bayer, BMS/Pfizer, Boehringer Ingelheim and Daiichi Sankyo. Dr. Basic is employee of Pfizer Deutschland GmbH. The authors have indicated that they have no other conflicts of interest regarding the content of this article.